« Previous
Next »
Fertility and Sterility
Volume 93, Issue 1
, Pages
184-191
, 1 January 2010
Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy
To access this article, please choose from the options below
H.J.T. has nothing to disclose. C.M. has nothing to disclose. S.K.H. has nothing to disclose. S.Z. has nothing to disclose. B.P.M. has served on the Cardiovascular Advisory Boards of Boehringer Ingelheim and Solvay Pharmaceuticals. L.J.M. has nothing to disclose.
This work was an investigator-initiated trial supported by a competitive Cardiovascular Lipid (CVL) Research Grant sponsored by Pfizer Australia and through internal department funds. H.J.T. received a National Health and Medical Research Council Career Development Award. L.J.M. received the Jean Hailes Fellowship.
PII: S0015-0282(08)03932-0
doi: 10.1016/j.fertnstert.2008.09.034
© 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Fertility and Sterility
Volume 93, Issue 1
, Pages
184-191
, 1 January 2010

